Skip to main content
. 2014 Oct 15;74(6):1261–1270. doi: 10.1007/s00280-014-2604-8

Fig. 1.

Fig. 1

Kaplan–Meier curves for a investigator-assessed PFS; b investigator-assessed duration of response (DR) among responders; and c overall survival (OS) stratified by histologic subtype. Data for PFS, DR, and OS were not collected in the axitinib extension study; therefore, results for the 13 patients who rolled over to the extension study were based on data collected from the original trial. CI confidence interval, NE non-estimable